3rd Quarter - Report
W STRATEGIES, LLC for GENZYME CORPORATION
Firm
Client
Income
$30,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Monitoring the implementation of the Patient Protection and Affordable Care Act, including provisions related to comparative effectiveness research, a regulatory pathway for biosimilars, and provisions related to orphan drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | House Rules Comm Assoc, Subcomm Staff Dir. |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.